ESC Premium Access

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes

Presentation

About the speaker

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
53 presentations
1 follower

5 more presentations in this session

FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

FIGARO-DKD - Discussant review.

Speaker: Doctor K. Damman (Groningen, NL)

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

Thumbnail

FIDELITY Analysis - Discussant review.

Speaker: Professor C. Baigent (Oxford, GB)

Thumbnail

FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Thumbnail

Access the full session

Hot Line - FIGARO-DKD / FIDELITY Analysis

Speakers: Professor G. Filippatos, Professor B. Pitt, Doctor K. Damman, Professor C. Baigent
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk